Mike Yeadon interview with Willem Engel on the pandemic, April 5
Below is a quick summary of Yeadon’s thoughts. Here is a link to his April 5 interview.
Similar Posts
Why is Swine Flu Still a Level 6 Pandemic?/ CDC
Here is the WHO report on current Swine Flu activity wordwide, and below is the CDC report for the US.
Avoiding Liability: The Drug Licensing Game the FDA Plays With The Department of Defense
From 2003: Click here to learn about 3 unusual licensing decisions, which circumvented liability for injuries caused by the following drug and vaccines: Example 1: Pyridostigmine bromide (aka PB or NAPS tablets). Example 2: Smallpox vaccine. Example 3: Anthrax vaccine. “Fully licensed” for the first 520,000 military recipients
“The AP and other press outlets have agreed not to report on suspected Ebola cases until a positive viral RNA test is completed”/ Forbes
And that could be why we are hearing so little despite multiple suspected cases around the country. Sunday, Nov. 2, someone recently returned from Liberia developed a fever, and was hospitalized at Duke. The publicy learned about this because a doctor at Duke is also a Forbes journalist, who had not signed on to the…
Maine disease rates and Maine vaccination rates/ Maine CDC
2016 Reportable Infectious Diseases Summary, Maine Scroll down to the Annual Reports to get to those for years 2003-2017 at the following URL: https://www.maine.gov/dhhs/mecdc/infectious-disease/epi/publications/#annualreports (Wish I could find a URL directly for the most recent, 2017 report, but so far have been unable to do so.) 2017-2018 Maine School Immunization Assessment Reports Table 1: 2017-18…
Gaming the Evidence: Evaluating adverse events post-vaccination/ BMJ rapid response
A letter to the BMJ questions the rationale for using certain new vaccines in India that fail to “result in significant reduction in disease burden” when older, cheaper and proven vaccines costing less than US $1.00 total per child are not being given to half the children in India. The letter also unmasks a scam…
Setting the Record Straight [when Glaxo Fakes the Data] / JAMA
Steve Nissen, head of Cardiology at the Cleveland Clinic, authored an editorial in JAMA last month on the means by which GlaxoSmithKline tried to cover up increased cardiac events in patients on its drug Avandia (Rosiglitazone). JAMA’s editor, Catherine DeAngelis, wrote her own editorial on this issue, noting: According to the article by Nissen,1 the…